POLYPOIDAL CHOROIDAL VASCULOPATHY (PCV)
Clinical trials for POLYPOIDAL CHOROIDAL VASCULOPATHY (PCV) explained in plain language.
Never miss a new study
Get alerted when new POLYPOIDAL CHOROIDAL VASCULOPATHY (PCV) trials appear
Sign up with your email to follow new studies for POLYPOIDAL CHOROIDAL VASCULOPATHY (PCV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized eye drops aim to stretch time between injections for blinding disease
Disease control Recruiting nowThis study is testing a personalized treatment schedule for a drug called faricimab, which is injected into the eye. It aims to control a serious eye disease called polypoidal choroidal vasculopathy (PCV), which can cause vision loss. The main goal is to see if patients can safel…
Matched conditions: POLYPOIDAL CHOROIDAL VASCULOPATHY (PCV)
Phase: PHASE3 • Sponsor: Yeungnam University College of Medicine • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New personalized eye treatment could stretch injections to every 4 months
Disease control Recruiting nowThis study is testing a personalized, high-dose version of an existing eye injection (aflibercept 8mg) for people with a specific eye condition called polypoidal choroidal vasculopathy (PCV). The goal is to see if this stronger dose, given on a flexible schedule, can effectively …
Matched conditions: POLYPOIDAL CHOROIDAL VASCULOPATHY (PCV)
Phase: PHASE3 • Sponsor: Yeungnam University College of Medicine • Aim: Disease control
Last updated Mar 02, 2026 15:25 UTC